JD

Jerel Davis

Managing Director at Versant Ventures

Greater Vancouver Metropolitan Area

Overview

Work Experience

VV

Versant Ventures

  • Managing Director

    2011 - Current

    Current companies: Ventus Tx, Turnstone, Tentarix, Santa Ana Bio, FireFly Tx, Kolm Tx, Fable Tx Previous companies: Chinook Tx (KDNY), RayzeBio, (RYZB), BlueRock (Acq. Bayer), Crispr Tx (CRSP), Repare Tx (RPTX), Quanticel Pharmaceuticals (Acq. Celgene), Akero Therapeutics (AKRO), Inception 4 (Acq. Iveric), Inception 5 (Acq. Roche), Northern Biologics (Acq. AZ and BI), Nested Tx, Graphite Bio

VT

Ventus Therapeutics

  • Board Chair

    2020

FB

Firefly Biologics

  • Board Member

    2022

SA

Santa Ana Bio

  • Board Member

    2022

TB

Turnstone Biologics

  • Board Member

    2015

GB

Graphite Bio

  • Board Member

    2020

NT

Nested Therapeutics

  • Board Member

    2022 - 2023

CT

Chinook Therapeutics, Inc.

  • Lead Board Director

    2019 - 2023

R

RayzeBio

  • Board Member

    2020 - 2023

Education

Investments

Firefly Bio

Series A

Total Funding: $94M

Tentarix Biotherapeutics

Series A

Total Funding: $85M

Santa Ana Bio

Series A

Total Funding: $170M

Ventus Therapeutics

Series A

Total Funding: $300M

Relevant Websites